Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

NCT04982471 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT04982471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04982471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Lead sponsor
Celgene
Phase
Observational
Overall status
Terminated
Start date
November 3, 2021
Completion date
August 3, 2023
Enrollment
36 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, follicular, lymphoma, large b-cell, diffuse, lymphoma, non-hodgkin